KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Gross Margin (2016 - 2025)

Historic Gross Margin for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to 20.81%.

  • Evolent Health's Gross Margin rose 78200.0% to 20.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.42%, marking a year-over-year increase of 24600.0%. This contributed to the annual value of 14.38% for FY2024, which is 90700.0% down from last year.
  • Per Evolent Health's latest filing, its Gross Margin stood at 20.81% for Q3 2025, which was up 78200.0% from 22.59% recorded in Q2 2025.
  • Evolent Health's Gross Margin's 5-year high stood at 33.77% during Q4 2021, with a 5-year trough of 11.71% in Q4 2024.
  • In the last 5 years, Evolent Health's Gross Margin had a median value of 22.49% in 2021 and averaged 22.14%.
  • Its Gross Margin has fluctuated over the past 5 years, first crashed by -120500bps in 2022, then surged by 78200bps in 2025.
  • Over the past 5 years, Evolent Health's Gross Margin (Quarter) stood at 33.77% in 2021, then tumbled by -36bps to 21.72% in 2022, then decreased by -16bps to 18.28% in 2023, then plummeted by -36bps to 11.71% in 2024, then soared by 78bps to 20.81% in 2025.
  • Its last three reported values are 20.81% in Q3 2025, 22.59% for Q2 2025, and 21.19% during Q1 2025.